Fig. 2From: A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case reportChromosome analysis showing complex hyperdiploidies. Hyperdiploidies were seen in three out of ten cells (3/10). Seven out of ten cells showed a normal karyotype (7/10). Similar hyperdiploidies remained until achieving stringent complete responseBack to article page